A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis

Nature Genetics

Volumn 35, Issue 4, 2003, Pages 349-356

  Helms, Cynthia ^a   Cao, Li ^a   Krueger, James G ^b   Wijsman, Ellen M ^c   Chamian, Francesca ^b   Gordon, Derek ^b   Heffernan, Michael ^a   Wright Daw, Jil A ^a   Robarge, Jason ^a   Ott, Jurg ^b   Kwok, Pui Yan ^d   Menter, Alan ^e   Bowcock, Anne M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; EZRIN; MOESIN; PHOSPHOPROTEIN; PROTEIN; PROTEIN RAPTOR; RADIXIN; RAPAMYCIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RUNX1; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CHROMOSOME 17Q; CHROMOSOME ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; EPITHELIUM; GENE; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MEMBRANE BIOLOGY; NAT9 GENE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PSORIASIS; SINGLE NUCLEOTIDE POLYMORPHISM; SYNAPSE; T LYMPHOCYTE;

ARYLAMINE N-ACETYLTRANSFERASE; BASE SEQUENCE; CARRIER PROTEINS; CHROMOSOMES, HUMAN, PAIR 17; CORE BINDING FACTOR ALPHA 2 SUBUNIT; DNA-BINDING PROTEINS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HLA-C ANTIGENS; HUMANS; JURKAT CELLS; LUCIFERASES; MALE; MOLECULAR SEQUENCE DATA; PHOSPHOPROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS; PSORIASIS; SKIN; SODIUM-HYDROGEN ANTIPORTER; T-LYMPHOCYTES; TRANSCRIPTION FACTORS;

HUMAN IMMUNODEFICIENCY VIRUS; RAPTORES; TOR;

EID: 0345659216     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/ng1268     Document Type: Article

References (30)

1. Menter, A. & Barker, J. Psoriasis in practice. Lancet 338, 231-234 (1991).
2. Duvic, M. Immunology of AIDS related to psoriasis. J. Invest. Dermatol. 95, 38S-40S (1990).
3. National Psoriasis Foundation Bulletin. Psoriatic arthritis more common than suspected. 33, 6 (2002).
4. Tiilikainen, A., Lassus, A., Karvonen, J., Vartiainen, P. & Julin, M. Psoriasis and HLA-Cw6. Brit. J. Dermatol. 102, 179-184 (1980).
5. Nair, R.P. et al. Localization of psoriasis-susceptibility locus PSORS1 to a 60-kb interval telomeric to HLA-C. Am. J. Hum. Genet. 66, 1833-1844 (2000).
6. Capon, F., Munro, M., Barker, J. & Trembath, R. Searching for the major histocompatibility complex psoriasis susceptibility gene. J. Invest. Dermatol. 118, 745-751 (2002).
7. Tomfohrde, J. et al. Gene for familial psoriasis susceptibility mapped to the distal end of human chromosome 17q. Science 264, 1141-1145 (1994).
8. Nair, R.P. et al. Evidence for two psoriasis susceptibility loci (HLA and 17q) and two novel candidate regions (16q and 20p) by genome-wide scan. Hum. Molec. Genet. 6, 1349-1356 (1997).
9. Enlund, F. et al. Analysis of three suggested psoriasis susceptibility loci in a large Swedish set of families: confirmation of linkage to chromosome 6p (HLA region), and to 17q, but not to 4q. Hum. Hered. 49, 2-8 (1999).
10. Bowcock, A.M. & Barker, J. Genetics of psoriasis: the potential impact on new therapies. J. Am. Acad. Dermatol. 49, S51-S56 (2003).
11. Reczek, D., Berryman, M. & Bretscher, A. Identification of EBP50: a PDZ-containing phosphoprotein that associates with members of the ezrin-radixin-moesin family. J. Cell Biol. 139, 169-179 (1997)
12. Itoh, K. et al. Cutting edge: negative regulation of immune synapse formation by anchoring lipid raft to cytoskeleton through Cbp-EBP50-ERM assembly. J. Immunol. 168, 541-544 (2002).
13. Kim, D.H. et al. mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 110, 163-175 (2002).
14. Hara, K. et al. Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. Cell 110, 177-189 (2002).
15. Prokunina, L. et al. A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nat. Genet. 32, 666-669 (2002).
16. Speckman, R.A. et al. Novel immunoglobulin superfamily gene cluster mapping to a region of human chromosome 17q25 harboring a locus for psoriasis susceptibility. Hum. Genet. 112, 31-41 (2002).
17. Bickeboller, H. & Clerget-Darpoux, F. Statistical properties of the allelic and genotypic transmission/disequilibrium test for multiallelic markers. Genet. Epidemiol. 12, 865-870 (1995).
18. Martin, E.R., Monks, S.A., Warren, L.L. & Kaplan, N.L. A test for linkage and association in general pedigrees: the pedigree disequilibrium test. Am. J. Hum. Genet. 67, 146-154 (2000).
19. Lacaud, G. et al. Runx1 is essential for hematopoietic commitment at the hemangioblast stage of development in vitro. Blood 100, 458-466 (2002).
20. Erickson, P. et al. Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1/ETO, with similarity to Drosophila segmentation gene, runt. Blood 80, 1825-1831 (1992).
21. Rudd, P.M., Elliott, T., Cresswell, P., Wilson, I.A. & Dwek, R.A. Glycosylation and the immune system. Science 291, 2370-2376 (2001).
22. Daniels, M.A., Hogquist, K.A. & Jameson, S.C. Sweet n' sour: the impact of differential glycosylation on T cell responses. Nat. Immunol. 3, 903-910 (2002).
23. Demetriou, M., Granovsky, M., Quaggin, S. & Dennis, J.W. Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation. Nature. 409, 733-739 (2001).
24. Renkonen, J., Tynninen, O., Hayry, P., Paavonen, T. & Renkonen, R. Glycosylation might provide endothelial zip codes for organ-specific leukocyte traffic into inflammatory sites. Am. J. Path. 161, 543-550 (2002).
25. Voltz, J.W., Weinman, E.J. & Shenolikar, S. Expanding the role of NHERF, a PDZ-domain containing protein adapter, to growth regulation. Oncogene 20, 6309-6314 (2001).
26. Taniuchi, I. et al. Differential requirements for Runx proteins in CD4 repression and epigenetic silencing during T lymphocyte development. Cell 111, 621-633 (2002).
27. Cookson, W.O. et al. Genetic linkage of childhood atopic dermatitis to psoriasis susceptibility loci. Nat. Genet. 27, 372-373 (2001).
28. Gordon, D., Heath, S.C., Liu, X. & Ott, J. A transmission/disequilibrium test that allows for genotyping errors in the analysis of single-nucleotide polymorphism data. Am. J. Hum. Genet. 69, 371-380 (2001).
29. Wijsman, E.M. A deductive method of haplotype analysis in pedigrees. Am. J. Hum. Genet. 41, 356-373 (1987).
30. Benjamini, Y., Drai, D., Elmer, G., Kafkafi, N. & Golani, I. Controlling the false discovery rate in behavior genetics research. Behav. Brain Res. 125, 279-284 (2001).